Difficulty: Medium
Average Score: 73%
Practice
Which one of the following drugs predictably prolongs the PR interval and increases cardiac contractility?
Correct answer
A
Rationale
In this question, the correct answer is A) Digoxin. Digoxin is a cardiac glycoside that acts by inhibiting the sodium-potassium pump, leading to an increase in intracellular calcium levels. This increase in calcium enhances cardiac contractility, making the heart muscle more efficient at pumping blood.
Digoxin also predictably prolongs the PR interval by slowing down the conduction of electrical impulses through the atrioventricular (AV) node. This effect is important to note as it can be seen on an electrocardiogram (ECG) when monitoring patients on digoxin therapy.
Now, let's discuss why the other options are incorrect:
- B) Lidocaine is a local anesthetic and antiarrhythmic drug that primarily works by blocking sodium channels in the heart to prevent abnormal electrical activity. It does not affect the PR interval or increase cardiac contractility.
- C) Propranolol is a beta-blocker that decreases heart rate and blood pressure by blocking beta-adrenergic receptors. It does not predictably prolong the PR interval or increase cardiac contractility.
- D) Quinidine is an antiarrhythmic medication that works by blocking sodium and potassium channels in the heart. While it can prolong the QT interval on an ECG, it does not specifically prolong the PR interval or increase cardiac contractility like digoxin.
In an educational context, understanding the effects of different cardiovascular drugs on the heart's electrical conduction system and contractility is crucial for healthcare professionals, especially those working in cardiology or critical care settings. Recognizing the unique actions of each medication helps in making informed decisions regarding treatment options and monitoring for potential side effects or complications.
Digoxin also predictably prolongs the PR interval by slowing down the conduction of electrical impulses through the atrioventricular (AV) node. This effect is important to note as it can be seen on an electrocardiogram (ECG) when monitoring patients on digoxin therapy.
Now, let's discuss why the other options are incorrect:
- B) Lidocaine is a local anesthetic and antiarrhythmic drug that primarily works by blocking sodium channels in the heart to prevent abnormal electrical activity. It does not affect the PR interval or increase cardiac contractility.
- C) Propranolol is a beta-blocker that decreases heart rate and blood pressure by blocking beta-adrenergic receptors. It does not predictably prolong the PR interval or increase cardiac contractility.
- D) Quinidine is an antiarrhythmic medication that works by blocking sodium and potassium channels in the heart. While it can prolong the QT interval on an ECG, it does not specifically prolong the PR interval or increase cardiac contractility like digoxin.
In an educational context, understanding the effects of different cardiovascular drugs on the heart's electrical conduction system and contractility is crucial for healthcare professionals, especially those working in cardiology or critical care settings. Recognizing the unique actions of each medication helps in making informed decisions regarding treatment options and monitoring for potential side effects or complications.